未登录
分享
收藏
分享
收藏The efficacy and safety of irinotecan plus raltitrexed as second-line treatment in advanced colorectal cancer (ACC) patients: A summary analysis of a multicenter, phase II trial
Qu, X.; Liu, Y.; Teng, Z.; Zhang, Y.; Zheng, D. Z.; Man, L.; Wang, Z.; Wang, Y.; Zhang, J.; Zhang, H.; Liu, J.; Chen, H.; Xiao, W. J.; Jiang, Y.; Zhang, J.; Liu, S.; Wang, C.
分享
收藏